Chi Van Dang

Chi Van Dang is a hematological oncologist and researcher, and the CEO and scientific director of Ludwig Institute for Cancer Research. as one of ten children. Dang's father was Chieu Van Dang, Vietnam's first neurosurgeon and was once the dean of the University of Saigon School of Medicine. his Ph.D in chemistry at Georgetown University in 1978, and M.D. from Johns Hopkins University, in 1982. At the University of California, San Francisco, he completed a fellowship on Hematology-Oncology training where he began to work with the MYC gene.

Career In 1987, Dang returned to Johns Hopkins where he took a faculty position. He was Director of the Division of Hematology at Johns Hopkins Hospital from 1993-2003. He also was Johns Hopkins Family Professor in Oncology Research. As of 2002, he became Vice Dean for Research,

As of September 1, 2011, Dang became the John H. Glick Professor of Medicine

As of July 1, 2017, Dang became the Scientific Director of the Ludwig Institute for Cancer Research, with the responsibility of overseeing the Institute's scientific strategy for studying the prevention, diagnosis, and treatment of cancer. The Ludwig Institute has branches in the United States, Switzerland, and the United Kingdom.

In 2018, Dang became Editor-in-Chief of Cancer Research, a peer-reviewed scientific journal published by the American Association for Cancer Research. He published his first editorial in January.

Research Dang's research has focused on cancer cells and genetics, notably on energy utilization of cancer cells.

Eric Fearon conducted his postdoctoral research in Dang's laboratory, where he developed a system for the study of protein-protein interactions in living mammalian cells.

Dang is also a proponent of chronotherapy, the idea that the delivery of drugs can be timed to take advantage of the body’s natural 24-hour rhythms, to minimize side effects and maximize treatment effectiveness. The National Cancer Institute has begun to support research into the function and regulation of clock genes and interactions between circadian rhythms, diseases, and treatments.

Awards 2018, Fellow, American Association for Cancer Research (AACR) 2012, Distinguished Alumnus Award for Scientific Achievement, Johns Hopkins University 2011, Fellow, American Academy of Arts and Sciences 2006, Member, National Academy of Medicine 2005, Golden Torch Award, Vietnamese-American National Gala 1997, Member, Association of American Physicians 1993, Member, American Society for Clinical Investigation